- Home
- FTS vs ZBH Comparison
FTS vs ZBH Comparison
Compare FTS & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTS
- ZBH
- Stock Information
- Founded
- FTS 1885
- ZBH 1927
- Country
- FTS Canada
- ZBH United States
- Employees
- FTS N/A
- ZBH N/A
- Industry
- FTS Electric Utilities: Central
- ZBH Industrial Specialties
- Sector
- FTS Utilities
- ZBH Health Care
- Exchange
- FTS Nasdaq
- ZBH Nasdaq
- Market Cap
- FTS 21.0B
- ZBH 20.8B
- IPO Year
- FTS N/A
- ZBH N/A
- Fundamental
- Price
- FTS $41.68
- ZBH $108.76
- Analyst Decision
- FTS
- ZBH Hold
- Analyst Count
- FTS 0
- ZBH 21
- Target Price
- FTS N/A
- ZBH $123.63
- AVG Volume (30 Days)
- FTS 526.2K
- ZBH 1.3M
- Earning Date
- FTS 02-07-2025
- ZBH 02-06-2025
- Dividend Yield
- FTS 4.18%
- ZBH 0.89%
- EPS Growth
- FTS 4.60
- ZBH 132.72
- EPS
- FTS 2.39
- ZBH 5.26
- Revenue
- FTS $8,471,075,906.00
- ZBH $7,595,500,000.00
- Revenue This Year
- FTS $4.54
- ZBH $4.76
- Revenue Next Year
- FTS $5.52
- ZBH $4.63
- P/E Ratio
- FTS $17.55
- ZBH $20.32
- Revenue Growth
- FTS N/A
- ZBH 4.35
- 52 Week Low
- FTS $36.86
- ZBH $101.47
- 52 Week High
- FTS $46.06
- ZBH $133.90
- Technical
- Relative Strength Index (RSI)
- FTS 27.54
- ZBH 48.83
- Support Level
- FTS $44.11
- ZBH $105.34
- Resistance Level
- FTS $45.01
- ZBH $110.45
- Average True Range (ATR)
- FTS 0.62
- ZBH 2.13
- MACD
- FTS -0.31
- ZBH -0.33
- Stochastic Oscillator
- FTS 3.46
- ZBH 42.66
About FTS Fortis Inc.
Fortis owns and operates eight utility transmission and distribution subsidiaries in Canada and the United States, serving more than 3.4 million electricity and gas customers. The company has smaller stakes in electricity generation and several Caribbean utilities. Subsidiary ITC operates electric transmission in seven US states, with more than 16,000 miles of high-voltage transmission lines in operation.
About ZBH Zimmer Biomet Holdings Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.